IP Library Granted Patent US 9,238,113
Granted Patent B2
US 9,238,113 · App. 12/877,836 · Granted Jan 19, 2016

Nasal respiratory devices for positive end-expiratory pressure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,113
App. No.
12/877,836
Granted
Jan 19, 2016
Kind
B2
Abstract

Described herein are nasal respiratory devices, in particular, nasal respiratory devices configured to achieve positive end-expiratory pressure (PEEP) in a subject wearing the device. PEEP devices may have a threshold pressure for opening during expiration. In some variations, these devices have a threshold pressure for closing during expiration.

Claims (32)

1. An adjustable nasal respiratory device for inhibiting expiration more than inspiration in a sleeping subject when worn in communication with a subject's nose, the device comprising:

an opening;

an adjustable airflow resistor in communication with the opening, wherein the airflow resistor is configured to inhibit expiration more than it inhibits inspiration, further wherein the resistance to expiration is adjustable; and

a holdfast configured to secure the nasal device in communication with the subject's nose without covering the subject's mouth.

2. The device of claim 1 further comprising a nasal airflow monitor to measure nasal airflow.

3. The device of claim 1 further comprising a leak path configured to be open during expiration.

4. The device of claim 1 , wherein the holdfast is an adhesive holdfast.

5. The device of claim 1 , wherein the holdfast is a shapeable holdfast.

6. The device of claim 1 , wherein the airflow resistor is configured to have a non-zero threshold for opening during expiration that is adjustable.

7. A method of treating a disorder using a nasal device configured to be worn by a sleeping subject, the method comprising:

securing a nasal respiratory device in communication with a subject's nasal cavity without covering the subject's mouth, wherein the nasal respiratory device is secured at least partially within the subject's nasal cavity, further wherein the nasal respiratory device includes an airflow resistor that has a non-zero threshold pressure for opening during expiration;

opening the airflow resistor from a closed position during expiration through the device when the pressure across the airflow resistor exceeds the threshold pressure for opening during expiration; and

providing a resistance to expiration through the airflow resistor that is greater than the resistance to inspiration.

8. The method of claim 7 further comprising closing the airflow resistor during expiration through the device when the pressure across the airflow resistor is below the threshold pressure for opening.

9. The method of claim 7 , wherein the disorder treated is selected from the group consisting of: respiratory disorders, sleep disorders, gastroenterologic disorders, and cardiovascular disorders.

10. The method of claim 7 , wherein the nasal respiratory device is secured at least partially over the subject's nasal cavity.

11. The method of claim 7 further comprising adjusting a resistance to expiration provided by the airflow resistor.

12. A nasal respiratory device for inducing positive end-expiratory pressure that is configured to be worn in communication with a subject's nose, the device comprising:

an opening;

an airflow resistor in communication with the opening, wherein the airflow resistor is configured to have a non-zero threshold pressure for opening from a closed position during expiration, so that the airflow resistor opens when the pressure across the airflow resistor exceeds the threshold pressure for opening during expiration, further

wherein the airflow resistor provides a resistance to expiration that is greater than the resistance to inspiration, and the resistance to expiration is adjustable; and

a holdfast configured to secure the entire device in communication with the subject's nose without covering the subject's mouth.

13. A nasal respiratory device for inducing positive end-expiratory pressure that is configured to be worn in communication with a subject's nose, the device comprising:

an opening;

an airflow resistor in communication with the opening, wherein the airflow resistor comprises a biased valve having a non-zero threshold pressure for opening during expiration, so that the airflow resistor opens from a closed position during expiration when the pressure across the valve exceeds the threshold pressure for opening, further wherein the airflow resistor comprises a second valve;

wherein the airflow resistor provides a resistance to expiration that is greater than the resistance to inspiration, and the resistance to expiration is adjustable and

a holdfast configured to secure the device in communication with the subject's nasal cavity or both nasal cavities but not the subject's mouth.

14. A nasal respiratory device for inducing positive end-expiratory pressure that is configured to be worn in communication with a subject's nose, the device comprising:

an opening;

an airflow resistor in communication with the opening, wherein the airflow resistor comprises a biased valve having a non-zero threshold pressure for opening during expiration, so that the airflow resistor opens from a closed position during expiration when the pressure across the valve exceeds the threshold pressure for opening, further

wherein the airflow resistor provides a resistance to expiration that is greater than the resistance to inspiration, and the resistance to expiration is adjustable; and

a holdfast configured to secure the device in communication with the subject's nasal cavity or both nasal cavities but not the subject's mouth.

Assignments (7)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 13, 2021
From: CERBERUS BUSINESS FINANCE, LLC
To: FOUNDATION CONSUMER HEALTHCARE, LLC (AS SUCCESSOR BY MERGER TO THERAVENT, INC.)
Reel/Frame 055301/0186 →
PATENT SECURITY AGREEMENT Recorded Feb 12, 2021
From: FOUNDATION CONSUMER HEALTHCARE, LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT
Reel/Frame 055297/0052 →
PATENT SECURITY AGREEMENT Recorded Nov 3, 2017
From: THERAVENT, INC.
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 044035/0575 →
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2017
From: NXT CAPITAL, LLC, AS AGENT
To: THERAVENT, INC.
Reel/Frame 044022/0361 →
SECURITY INTEREST Recorded Mar 30, 2017
From: THERAVENT, INC.
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041794/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS MEDICAL, INC.
To: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS) LLC
Reel/Frame 030865/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: THERAVENT, INC.
Reel/Frame 030865/0949 →